Commentary
This article aims to provide contextual information for a general audience interested in conducting or evaluating cost-of-illness studies that may include drug costs and to describe key factors to consider when reviewing drug costs in the peer-reviewed literature.
Corrigendum
The authors wish to make the following corrections to their article: Clements JN. Diabetes: how to manage chronic kidney disease. Drugs Context. 2022;11:2021-9-10. https://doi.org/10.7573/dic.2021-9-10
Review
This study aims to describe the characteristics of pharmacy practice in Latin America by reviewing the related literature published over the last 5 years assessing the scope and characteristics of pharmacy practice in the region.
Review
This article reviews the biology, clinicopathological characteristics, targeted therapies and mechanisms of resistance of advanced non-small-cell lung cancer harbouring RET fusions to provide treatment guidance for these patients.
Review
This article provides a review of the current treatment approaches to advanced non-small-cell lung cancer in patients without molecular driver alterations, with an additional focus on special populations, concomitant medications, and other considerations that might be useful for daily clinical practice.
